Clinical trial · Observational
Association of Psychological Distress in Patients With Lung Cancer
the Association of Psychological Distress in Patients With Advanced Lung Cancer Treated With Immunotherapy or Targeted Therapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Psychological distress is a multi-factorial experience of a psychological, social, spiritual, and/or physical nature that may interfere with one's ability to cope effectively with cancer, physical symptoms and treatment. Psychological distress is common and affects the efficacy and prognosis of patients with lung cancer. The systematic anti-tumor therapy may effectively relieve psychological distress including anxiety, depression, and fatigue in patients with advanced lung cancer, the relief of the psychological distress can in turn improve the therapeutic effect. In summary, this study is to explore the associations of (dynamic) psychological stress with the efficacy and survival of anti-tumor therapy including immunotherapy and targeted therapy for advanced lung cancer patients.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| IMMUNOTHERAPY | — | UNRESOLVED | — |
| Lifestyle, Healthy | — | UNRESOLVED | — |
| Lung Neoplasms | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Prognosis Factors | — | UNRESOLVED | — |
| Psychological Distress | — | UNRESOLVED | — |
| Targeted Molecular Therapy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| immunotherapy | Drug | Immunotherapy | ALIAS |
| Targeted Therapy Agent | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Objective response rate (ORR)
- timeFrame
- 20 years
- description
- Collect detailed clinical information on patients with SCLC via the electronic medical records
- measure
- Disease control rate (DCR)
- timeFrame
- 20 years
- description
- Collect detailed clinical information on patients with SCLC via the electronic medical records
- measure
- Progression-free survival (PFS)
- timeFrame
- 20 years
- description
- Collect detailed clinical information on patients with SCLC via the electronic medical records
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven diagnosis of lung cancer * 18 years of age or older * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Not willing to participate in this clinical trial
References
Publications (0)
Data not yet available